Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

Ann Surg Oncol. 2021 Aug;28(8):4095-4097. doi: 10.1245/s10434-021-10112-z. Epub 2021 May 17.

¹ Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.
² Section of Colorectal Surgery, Division of Surgery, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
³ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. vankmorris@mdanderson.org.
⁴ Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Building 10, Room 4-3740, Bethesda, MD, 20892, USA. jonathan.hernandez@nih.gov.

No abstract available

Publication types